
Cystic fibrosis treatment could improve lung function
A new treatment for cystic fibrosis (CF) could improve lung function in patients, results suggest. ETD001, developed by biopharmaceutical company Enterprise Therapeutics, was trialled in a Phase II study as an inhaled treatment in the 10% of people with CF with the highest unmet medical need, who do… Read More


